MENOPAUSE
The calm after the chaos
Reviewed Dr Jo Mackson, MBBS FRACGP
Published June 2026
Reading time About 9 minutes
This guide follows our Late Reproductive Stage and Perimenopause guides. If you are not yet 12 months past your last period, those are the ones to start with. If you are, welcome to the third chapter: what menopause actually is, and how to think about the years that follow.
What menopause actually is.
Menopause is defined as 12 consecutive months without a period, with no other cause behind the gap. That is the whole definition. It is a single point in time, and you can only know it has arrived once those 12 months have passed, which makes it a diagnosis confirmed in hindsight. In Australia the average age is 51, with most women reaching it somewhere between 45 and 55. Around the world the average ranges from roughly 45 to 52, varying with ancestry, nationality, and overall health. Menopause before 45 is considered early, and before 40 it is called premature ovarian insufficiency, which is a different situation with its own approach.
What has happened hormonally is, for once, fairly straightforward. The ovaries have wound down their reproductive work, ovulation has stopped, and oestrogen and progesterone have settled at persistently low levels. The volatility of perimenopause, the spikes and crashes, is over. What replaces it is a new and steadier hormonal landscape: low, but stable. For many women that steadiness is a relief after years of unpredictability. But sustained low oestrogen, alongside the loss of progesterone, brings its own consequences, some you feel and some that are quiet but matter over time. This guide is about both.
Menopause is not the end of something. It is a biological milestone that opens a life stage that deserves every bit as much clinical attention as the decades that came before it.
This guide is about menopause that arrives naturally, over time. Menopause that comes on suddenly, after both ovaries are removed, is a different situation altogether. The drop is abrupt rather than gradual, the symptoms can hit harder, and the treatment approach differs, especially for younger women. It is important enough to have its own Mini Guide. Read it here.
Making the symptoms make sense.
Not every woman gets every symptom, and severity varies enormously. Some find postmenopause a relief. Others find a new set of challenges waiting on the other side. Both are normal, and the range of normal is wider than most people are led to believe. Most of what you might feel comes back to the ovaries winding down: oestrogen, which has receptors on nearly every tissue in the body, is now persistently low, and progesterone, with its own calming and sleep-supporting role, is essentially gone.
Hot flushes and night sweats, the symptoms doctors call vasomotor symptoms, often carry on from perimenopause into the early postmenopausal years before gradually easing, though for some women they last a decade or more. This happens because falling oestrogen narrows the comfort zone of the brain’s internal thermostat. With that margin reduced, a small rise in body temperature that you would normally not notice is read as overheating, and the body responds by flushing and sweating to cool itself down.
Sleep can stay broken, partly from night sweats and partly because both oestrogen and progesterone had a hand in regulating it. For most women, the mood swings of perimenopause settle once the hormonal volatility passes. For some, particularly those who have always been sensitive to hormonal change, low mood or anxiety can linger, and it still deserves attention. The brain fog of perimenopause, the word-finding blanks and the lost concentration, tends to lift as stability returns, and for most women that sharpness comes back rather than fading for good.
Falling oestrogen can also affect joints, skin, and connective tissue, which can show up as joint pain and stiffness, skin changes, and even pelvic floor issues. Libido often drops too. Part of that is low oestrogen, part is simply not feeling your best, and part is a separate hormonal shift that comes with age rather than menopause itself: a slow decline in testosterone, which has a role in desire.
There is one more driver of low libido, equally under-discussed, and it deserves its own moment, because unlike hot flushes it does not get better on its own. Genitourinary syndrome of menopause, or GSM, covers the changes that low oestrogen brings to the vaginal, vulval, and urinary tissues, which are among the most oestrogen-dependent in the body. As oestrogen drops, these tissues thin, lose elasticity, and become more fragile. The result can be vaginal dryness, irritation, and pain with sex, along with urinary urgency, discomfort, and recurrent urinary tract infections. Left alone, GSM is progressive. Treated, it responds well, most often to low-dose vaginal oestrogen delivered straight to the tissues, which is safe for long-term use and barely absorbed into the rest of the body.
Vaginal dryness, pain with sex, urinary urgency, and recurrent urinary tract infections are common after menopause, and they are very treatable. Many women never raise them, because they feel embarrassing, or because someone once said they were just part of getting older. They are neither. So if any of this sounds familiar, please mention it. It is one of the simplest things to put right, and few changes do more for everyday comfort and quality of life.
Once you are 12 months past your last period and not taking MHT, the bleeding should be over for good. Any vaginal bleeding after that point, even light spotting, needs checking promptly, because it is the main warning sign of cancer of the uterine lining, which is very treatable when caught early. MHT changes the picture. On the continuous kind, some unscheduled bleeding is common in the first six months while the body settles. Beyond six months, or if bleeding returns after it had stopped, it should be checked. On the cyclical kind, a regular, predictable monthly bleed is expected, and it is bleeding outside that pattern, heavier, longer, or at an unexpected time, that needs reviewing.
Now, how can we help?
The conversation about what to do has two halves: the foundations, and the treatments that sit on top of them. The foundations come first, and they are powerful. How you eat, move, sleep, and handle stress shapes both how you feel now and how well you carry the decades ahead, and the evidence behind that is strong. We know how it can land. “Eat well, sleep more, exercise” is advice most women have heard a hundred times, often instead of being properly listened to. We get the eye-roll. But the evidence is on the side of the foundations, and for some women and some symptoms they do as much as anything we can prescribe. If we could bottle a Mediterranean diet, eight hours of sleep, two resistance sessions, and 50K steps a week, we would. The day that becomes possible, you will be the first to know. Until then, the effort is worth it, and we walk you through all of it in our Midlife Lifestyle Advice Deep Dive.
One upside of reaching menopause is that contraception is no longer needed. The timing depends on your age. If you are 50 or over, you are clear 12 months after your last period. If you are under 50, the guideline is 24 months, because periods can still make a comeback.
On top of the foundations sits menopausal hormone therapy, or MHT, the term now used in place of HRT. It is the most effective treatment for the hormonal symptoms of menopause, and the modern version looks quite different from the one many women grew up fearing. The current first-line approach for most women with a uterus is oestradiol, given through the skin as a patch or gel, or as a tablet, paired with micronised progesterone, or another progestogen taken as a tablet, a patch, or released from an IUD. The skin route for oestrogen carries a lower clotting risk than tablets, and micronised progesterone has a more favourable breast cancer profile than the older synthetic progestogens. There are many options and variations of MHT, each with its own balance of benefits, risks, and trade-offs. It is not one-size-fits-all, not in the preparation, not in the dose, and not in how long it is used for, so the right approach is best worked out with your GP, around your symptoms, your medical history, and your age.
While there are many nuances to MHT prescribing, one principle is close to universal. If you have a uterus, or you do not but you have a history of endometriosis, you must always take a progestogen or progesterone alongside oestradiol. With a uterus, oestrogen on its own makes the lining build up over time, which can increase the risk of endometrial cancer. With a history of endometriosis, the same logic applies to any deposits left behind, which stay responsive to oestrogen even after the uterus is gone. Women without a uterus and without that history generally do not need it, though for some it still has a role for other reasons, so it is worth raising with your doctor.
This is the question that stops more women starting MHT than any other, and the fear behind it has caused harm of its own. It traces back to the 2002 WHI study, whose alarming early headlines have outlived the study itself and do not reflect how MHT is prescribed today. That fear is not harmless. Women who would have felt better on MHT, and who would have gained protection for their bones and heart, have gone without it and been worse off for the decision. Whether MHT is right for you depends on your own breast cancer risk, with and without hormones, and that is worth working through properly with your doctor, free of the fear the headlines left behind.
If hormones are not right for you, by choice or by circumstance, there are non-hormonal options with evidence behind them: fezolinetant, a newer medication for hot flushes; certain antidepressants, which reduce flushes and often lift mood at the same time; and cognitive behavioural therapy, which does not stop flushes but changes how much they disrupt you.
Supplements are where the evidence is most uneven, and the marketing loudest. Sorted by how much sits behind them, they fall roughly into three groups.
- Vitamin D & B12replacing a deficiency
- Magnesiumsleep and muscle
- Creatinemuscle, strength, cognition
- Phytoestrogenshot flushes
- Saffronmood
- Shatavarimood, hot flushes, libido
Whatever you are considering, bring it to your doctor first, because some interact with medications and some are not safe in particular conditions.
Testosterone comes up a lot in menopause conversations, though its decline is not really a menopause event. It falls slowly with age, in a slide that happens to overlap with these years. The evidence supports a trial of testosterone for a persistent and distressing loss of sexual desire. Beyond desire, many women and the doctors who treat them report better energy, mood, and mental sharpness, though the formal trial evidence has not yet caught up with those reports. That gap, between strong clinical experience and proven effect, is exactly why it is worth talking through with your GP, especially if low libido or low energy lingers despite adequate oestrogen.
The longer view.
Menopause is not only about how you feel day to day. Low oestrogen also drives changes you cannot feel, and these are the ones worth getting ahead of. Bone loss speeds up in the first few years after menopause, which is why the risk of osteoporosis and fracture climbs later on. Cardiovascular disease becomes the leading cause of death in women after menopause, ahead of all cancers combined, as the protection oestrogen once gave the heart and blood vessels falls away. And metabolism shifts, with weight settling more around the middle and insulin working less efficiently than before. These are the parts of menopause most worth getting ahead of, and they respond best when you start early. The Deep Dive covers exactly how.
The decades after menopause can be among a woman’s best. With good care allowing you to feel your best and protect your health for the long run, these are years you can thrive in.
So there you have it. Our Mini Guide on menopause. If we’ve left you at all curious about the deeper science, or wanting a proper walk through the treatment options, our Deep Dive is where to go next.
This Mini Guide is the taste test. The Deep Dive is the full degustation. It covers every tasty morsel: the MHT and breast cancer numbers put in their proper context, why the 2002 study that scared a generation off hormones studied the wrong women, and what testosterone can and cannot do for you.
It is long. It is detailed. It is the education on this stage we think every woman should have had years ago. We are not going to insist you read it. Life is busy, and “long-form medical education” is not on every woman’s reading list. But if you ever find yourself wondering, the Deep Dive is here when you are. Read it here.